127 related articles for article (PubMed ID: 16681644)
1. Recombinant human activated protein C upregulates the release of soluble fractalkine from human endothelial cells.
Brueckmann M; Nahrup AS; Lang S; Bertsch T; Fukudome K; Liebe V; Kaden JJ; Hoffmann U; Borggrefe M; Huhle G
Br J Haematol; 2006 Jun; 133(5):550-7. PubMed ID: 16681644
[TBL] [Abstract][Full Text] [Related]
2. Recombinant human activated protein C upregulates cyclooxygenase-2 expression in endothelial cells via binding to endothelial cell protein C receptor and activation of protease-activated receptor-1.
Brueckmann M; Horn S; Lang S; Fukudome K; Schulze Nahrup A; Hoffmann U; Kaden JJ; Borggrefe M; Haase KK; Huhle G
Thromb Haemost; 2005 Apr; 93(4):743-50. PubMed ID: 15841323
[TBL] [Abstract][Full Text] [Related]
3. Fractalkine is not a major chemoattractant for the migration of neutrophils across microvascular endothelium.
Beck GCh; Ludwig F; Schulte J; van Ackern K; van der Woude FJ; Yard BA
Scand J Immunol; 2003 Aug; 58(2):180-7. PubMed ID: 12869139
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of platelet-derived growth factor in patients with severe sepsis.
Brueckmann M; Hoffmann U; Engelhardt C; Lang S; Fukudome K; Haase KK; Liebe V; Kaden JJ; Putensen C; Borggrefe M; Huhle G
Growth Factors; 2007 Feb; 25(1):15-24. PubMed ID: 17454146
[TBL] [Abstract][Full Text] [Related]
5. Chemokine fractalkine mediates leukocyte recruitment to inflammatory endothelial cells in flowing whole blood: a critical role for P-selectin expressed on activated platelets.
Schulz C; Schäfer A; Stolla M; Kerstan S; Lorenz M; von Brühl ML; Schiemann M; Bauersachs J; Gloe T; Busch DH; Gawaz M; Massberg S
Circulation; 2007 Aug; 116(7):764-73. PubMed ID: 17679613
[TBL] [Abstract][Full Text] [Related]
6. Soluble interleukin-6 receptor alpha inhibits the cytokine-Induced fractalkine/CX3CL1 expression in human vascular endothelial cells in culture.
Matsumiya T; Imaizumi T; Fujimoto K; Cui X; Shibata T; Tamo W; Kumagai M; Tanji K; Yoshida H; Kimura H; Satoh K
Exp Cell Res; 2001 Sep; 269(1):35-41. PubMed ID: 11525637
[TBL] [Abstract][Full Text] [Related]
7. Fractalkine-mediated endothelial cell injury by NK cells.
Yoneda O; Imai T; Goda S; Inoue H; Yamauchi A; Okazaki T; Imai H; Yoshie O; Bloom ET; Domae N; Umehara H
J Immunol; 2000 Apr; 164(8):4055-62. PubMed ID: 10754298
[TBL] [Abstract][Full Text] [Related]
8. CX(3)C chemokine fractalkine in pulmonary arterial hypertension.
Balabanian K; Foussat A; Dorfmüller P; Durand-Gasselin I; Capel F; Bouchet-Delbos L; Portier A; Marfaing-Koka A; Krzysiek R; Rimaniol AC; Simonneau G; Emilie D; Humbert M
Am J Respir Crit Care Med; 2002 May; 165(10):1419-25. PubMed ID: 12016106
[TBL] [Abstract][Full Text] [Related]
9. Tumor necrosis factor-alpha stimulates fractalkine production by mesangial cells and regulates monocyte transmigration: down-regulation by cAMP.
Chen YM; Lin SL; Chen CW; Chiang WC; Tsai TJ; Hsieh BS
Kidney Int; 2003 Feb; 63(2):474-86. PubMed ID: 12631113
[TBL] [Abstract][Full Text] [Related]
10. CX3C-chemokine, fractalkine-enhanced adhesion of THP-1 cells to endothelial cells through integrin-dependent and -independent mechanisms.
Goda S; Imai T; Yoshie O; Yoneda O; Inoue H; Nagano Y; Okazaki T; Imai H; Bloom ET; Domae N; Umehara H
J Immunol; 2000 Apr; 164(8):4313-20. PubMed ID: 10754331
[TBL] [Abstract][Full Text] [Related]
11. Resveratrol suppresses tumor necrosis factor-alpha-induced fractalkine expression in endothelial cells.
Moon SO; Kim W; Sung MJ; Lee S; Kang KP; Kim DH; Lee SY; So JN; Park SK
Mol Pharmacol; 2006 Jul; 70(1):112-9. PubMed ID: 16614140
[TBL] [Abstract][Full Text] [Related]
12. Interferon-gamma stimulates the expression of CX3CL1/fractalkine in cultured human endothelial cells.
Imaizumi T; Matsumiya T; Fujimoto K; Okamoto K; Cui X; Ohtaki U; Hidemi ; Yoshida ; Satoh K
Tohoku J Exp Med; 2000 Oct; 192(2):127-39. PubMed ID: 11211312
[TBL] [Abstract][Full Text] [Related]
13. Protective effect of alpha-lipoic acid in lipopolysaccharide-induced endothelial fractalkine expression.
Sung MJ; Kim W; Ahn SY; Cho CH; Koh GY; Moon SO; Kim DH; Lee S; Kang KP; Jang KY; Park SK
Circ Res; 2005 Oct; 97(9):880-90. PubMed ID: 16166554
[TBL] [Abstract][Full Text] [Related]
14. Expression of CX3C chemokine, fractalkine, and its receptor CX3CR1 in experimental autoimmune anterior uveitis.
Fang IM; Lin CP; Yang CM; Chen MS; Yang CH
Mol Vis; 2005 Jul; 11():443-51. PubMed ID: 16030495
[TBL] [Abstract][Full Text] [Related]
15. Protein overload induces fractalkine upregulation in proximal tubular cells through nuclear factor kappaB- and p38 mitogen-activated protein kinase-dependent pathways.
Donadelli R; Zanchi C; Morigi M; Buelli S; Batani C; Tomasoni S; Corna D; Rottoli D; Benigni A; Abbate M; Remuzzi G; Zoja C
J Am Soc Nephrol; 2003 Oct; 14(10):2436-46. PubMed ID: 14514721
[TBL] [Abstract][Full Text] [Related]
16. Fractalkine is an epithelial and endothelial cell-derived chemoattractant for intraepithelial lymphocytes in the small intestinal mucosa.
Muehlhoefer A; Saubermann LJ; Gu X; Luedtke-Heckenkamp K; Xavier R; Blumberg RS; Podolsky DK; MacDermott RP; Reinecker HC
J Immunol; 2000 Mar; 164(6):3368-76. PubMed ID: 10706732
[TBL] [Abstract][Full Text] [Related]
17. Fractalkine is expressed by smooth muscle cells in response to IFN-gamma and TNF-alpha and is modulated by metalloproteinase activity.
Ludwig A; Berkhout T; Moores K; Groot P; Chapman G
J Immunol; 2002 Jan; 168(2):604-12. PubMed ID: 11777952
[TBL] [Abstract][Full Text] [Related]
18. Enhanced recruitment of CX3CR1+ T cells by mucosal endothelial cell-derived fractalkine in inflammatory bowel disease.
Sans M; Danese S; de la Motte C; de Souza HS; Rivera-Reyes BM; West GA; Phillips M; Katz JA; Fiocchi C
Gastroenterology; 2007 Jan; 132(1):139-53. PubMed ID: 17241867
[TBL] [Abstract][Full Text] [Related]
19. Activated protein C alters cytosolic calcium flux in human brain endothelium via binding to endothelial protein C receptor and activation of protease activated receptor-1.
Dömötör E; Benzakour O; Griffin JH; Yule D; Fukudome K; Zlokovic BV
Blood; 2003 Jun; 101(12):4797-801. PubMed ID: 12586611
[TBL] [Abstract][Full Text] [Related]
20. Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, in periodontal diseased tissue.
Hosokawa Y; Nakanishi T; Yamaguchi D; Nakae H; Matsuo T
Clin Exp Immunol; 2005 Mar; 139(3):506-12. PubMed ID: 15730397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
